SMi 13th annual Superbugs & Superdrugs

Venue: Millennium Gloucester Hotel

Location: London, United Kingdom

Event Date/Time: Mar 16, 2011 End Date/Time: Mar 17, 2011
Report as Spam


SMi Group's Superbugs & Superdrugs conference taking place on the 16th and 17th of March 2011, with over 25 high level speakers hailing from top pharma, biotech and academia, this conference will deliver case study focused practical presentations enabling you to learn from the best.

• Michael Gwynn, Director, Microbiology, Infectious Diseases CEDD, GlaxoSmithKline
• Neil Ryder, Executive Director, Infectious Diseases, Novartis Institutes for Biomedical Research
• Erin Duffy, Vice President, Discovery Research, Rib-X Pharmaceuticals
• Penny Heaton, Head of Clinical Research and Development Clusters, Novartis Vaccines and Diagnostics
• Jacques Dumas, Associate Director, Infection Chemistry, AstraZeneca
• Laurent Fraisse, Head of Infectious Disease Research, Sanofi-Aventis
• Malcolm Page, Head of Biology, Basilea Pharmaceutica
• Barry Eisenstein, Senior VP, Scientific Affairs, Cubist Pharmaceuticals


Additional Information

PLUS A HALF DAY PRE-CONFERENCE WORKSHOP Translating Innovation to Success in Antimicrobial Drug Discovery and Development 15th March 2011, London Hosted by industry experts including senior representatives from Polymedix and Cubist Pharmaceuticals This workshop will provide insights into the stages of the antimicrobial drug discovery process with the goal of increasing the probability of success.